{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:17:02Z","timestamp":1788905822618,"version":"build-2803163510"},"reference-count":78,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Breast cancer care is a costly global health issue where effective management depends on early detection and treatment. A breast cancer diagnosis can result in financial catastrophe especially in low- and middle-income countries (LMIC). Large inequities in breast cancer care are observed and represent a global challenge to caregivers and patients. Strategies to improve early diagnosis include awareness and clinical breast examination in LMIC, and screening in high-income countries (HIC). The use of clinical guidelines for the management of breast cancer is needed. Adapted guidelines from HIC can address disparities in populations with limited resources. Locally developed strategies still provide effective guidance in improving survival. Integrated practice units (IPU) with timely multidisciplinary breast care conferences and patient navigators are required to achieve high-value, personalized breast cancer management in HIC as well as LMIC. Breast cancer patient care should include a quality of life evaluation using ideally patient-reported outcomes (PROM) and experience measurements (PREM). Evaluation of breast cancer outcomes must include the financial cost of delivered care. The resulting value perspective should guide resource allocation and program priorities. The value of care must be improved by translating the findings of social and economic research into practice and resolving systemic inequity in clinical breast cancer research. Cancer survivorship programs must be put in place everywhere. The treatment of patients with metastatic breast cancer must require more attention in the future, especially in LMIC.<\/jats:p>","DOI":"10.1093\/oncolo\/oyae080","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T12:01:50Z","timestamp":1716465710000},"page":"e899-e909","source":"Crossref","is-referenced-by-count":14,"title":["High-value breast cancer care within resource limitations"],"prefix":"10.1093","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7748-0837","authenticated-orcid":false,"given":"Didier","family":"Verhoeven","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, University of Antwerp, AZ KLINA , Brasschaat , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Siesling","sequence":"additional","affiliation":[{"name":"Department of Health Technology and Services Research, Technical Medical Centre, University of Twente , Enschede , The Netherlands"},{"name":"Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL) , Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4871-3766","authenticated-orcid":false,"given":"Claudia","family":"Allemani","sequence":"additional","affiliation":[{"name":"Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj Gupta","family":"Roy","sequence":"additional","affiliation":[{"name":"Nuffield Department of Surgical Sciences, University of Oxford , Oxford , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luzia","family":"Travado","sequence":"additional","affiliation":[{"name":"Champalimaud Clinical and Research Centre, Champalimaud Foundation , Lisbon , Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala","family":"Bhoo-Pathy","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Malaya, Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford","family":"Rhayns","sequence":"additional","affiliation":[{"name":"Just4Cancer , Las Vegas , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Junkermann","sequence":"additional","affiliation":[{"name":"Mammographie-Screening Neckar-Alb , T\u00fcbingen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seigo","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Breast Surgical Oncology, Department of Surgery, Showa University , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nwamaka","family":"Lasebikan","sequence":"additional","affiliation":[{"name":"Department of Radiation and Clinical Oncology, University of Nigeria Teaching Hospital , Enugu , Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forrest Lee","family":"Tucker","sequence":"additional","affiliation":[{"name":"Virginia Biomedical Laboratories , Wirtz, VA , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"issue":"10125","key":"2024070511380435500_CIT0001","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-2014 (CONCORD-3): analysis of individual records for 37,513,025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"2024070511380435500_CIT0002","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4274\/ejbh.galenos.2021.2021-1-1","article-title":"New frontiers for fairer breast cancer care in a globalized world","volume":"17","author":"Verhoeven","year":"2021","journal-title":"Eur J Breast Health"},{"key":"2024070511380435500_CIT0003","volume-title":"Breast Cancer: Global Quality Care","author":"Verhoeven","year":"2020"},{"issue":"10330","key":"2024070511380435500_CIT0004","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0140-6736(22)00184-2","article-title":"The lancet breast cancer commission: tackling a global health, gender and equity challenge","volume":"399","author":"Coles","year":"2022","journal-title":"Lancet"},{"key":"2024070511380435500_CIT0005","article-title":"Cancer incidence in five continents","author":"Bray"},{"key":"2024070511380435500_CIT0006","volume-title":"Global Cancer Observatory: Cancer Today","author":"Ferlay"},{"issue":"10","key":"2024070511380435500_CIT0007","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1158\/1055-9965.EPI-15-0535","article-title":"International variation in female breast cancer incidence and mortality rates","volume":"24","author":"De Santis","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2024070511380435500_CIT0008","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.1002\/cncr.30988","article-title":"Disparities in breast cancer survival in the United States (2001-2009): findings from the CONCORD-2 study","volume":"123","author":"Miller","year":"2017","journal-title":"Cancer"},{"issue":"6","key":"2024070511380435500_CIT0009","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3322\/caac.21412","article-title":"Breast cancer statistics, 2017, racial disparities in mortality by state","volume":"67","author":"De Santis","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"2024070511380435500_CIT0010","volume-title":"Human Development Index","author":"Max","year":"2014"},{"issue":"4","key":"2024070511380435500_CIT0011","doi-asserted-by":"crossref","first-page":"244","DOI":"10.6061\/clinics\/2017(04)09","article-title":"Breast cancer screening in developing countries","volume":"72","author":"Rene Aloisio da Costa","year":"2017","journal-title":"Clinics (Sao Paulo)"},{"key":"2024070511380435500_CIT0012","volume-title":"Population Screening for Breast Cancer: Expectations and Developments","author":"Health Council of the Netherlands","year":"2014"},{"issue":"9855","key":"2024070511380435500_CIT0013","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0140-6736(12)61611-0","article-title":"The benefits and harms of breast cancer screening: an independent review","volume":"380","author":"Independent UK Panel on Breast Cancer Screening","year":"2012","journal-title":"Lancet"},{"key":"2024070511380435500_CIT0014","author":"European Commission Initiative on Breast Cancer"},{"key":"2024070511380435500_CIT0015","doi-asserted-by":"crossref","first-page":"g5410","DOI":"10.1136\/bmj.g5410","article-title":"Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study","volume":"349","author":"de Glas","year":"2014","journal-title":"BMJ."},{"issue":"8","key":"2024070511380435500_CIT0016","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/annonc\/mdq633","article-title":"Advanced breast cancer incidence following population-based mammographic screening","volume":"22","author":"Autier","year":"2011","journal-title":"Ann Oncol"},{"issue":"7","key":"2024070511380435500_CIT0017","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/s41416-020-0968-6","article-title":"Impact of mammographic screening and advanced cancer definition on the percentage of advanced-stage cancers in a steady-state breast screening programme in the Netherlands","volume":"123","author":"de Munck","year":"2020","journal-title":"Br J Cancer"},{"key":"2024070511380435500_CIT0018","volume-title":"TNM Classification of Malignant Tumours","author":"Brierley","year":"2017","edition":"8"},{"issue":"3","key":"2024070511380435500_CIT0019","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ijc.32767","article-title":"Breast cancer incidence and mortality before and after implementation of the German mammography screening program","volume":"147","author":"Katalinic","year":"2020","journal-title":"Int J Cancer"},{"issue":"31-32","key":"2024070511380435500_CIT0020","first-page":"538","article-title":"Trends over time in breast-cancer-specific mortality in Germany","volume":"118","author":"Waldmann","year":"2021","journal-title":"Dtsch Arztebl Int"},{"key":"2024070511380435500_CIT0021","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.breast.2022.04.003","article-title":"Global guidelines for breast cancer screening: a systematic review","volume":"64","author":"Ren","year":"2022","journal-title":"Breast"},{"issue":"1","key":"2024070511380435500_CIT0022","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clon.2020.07.007","article-title":"Long-term survival outcomes of \u201clow risk\u201d ductal carcinoma in situ from a territory-wide cancer registry","volume":"33","author":"Co","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"2024070511380435500_CIT0023","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s12885-022-09484-6","article-title":"Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the \u201cMy Personal Breast Screening\u201d (MyPeBS) randomised clinical trial","volume":"22","author":"Roux","year":"2022","journal-title":"BMC Cancer"},{"key":"2024070511380435500_CIT0024","doi-asserted-by":"crossref","first-page":"04048","DOI":"10.7189\/jogh.12.04048","article-title":"Economic evaluations of mammography to screen for breast cancer in low- and middle-income countries: a systematic review","volume":"12","author":"Icanervilia","year":"2022","journal-title":"J Glob Health"},{"issue":"1","key":"2024070511380435500_CIT0025","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1186\/s12885-020-07521-w","article-title":"Effectiveness of clinical breast examination as a \u201cstand-alone\u201d screening modality: an overview of systematic reviews","volume":"20","author":"Ngan","year":"2020","journal-title":"BMC Cancer"},{"issue":"2","key":"2024070511380435500_CIT0026","first-page":"108","article-title":"The fundamental flaws of the CNBSS Trials: a scientific review","volume":"4","author":"Jean","year":"2022","journal-title":"J"},{"issue":"2","key":"2024070511380435500_CIT0027","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/jbi\/wbac004","article-title":"Problems with the Canadian national breast screening studies","volume":"4","author":"Duffy","year":"2022","journal-title":"J Breast Imaging"},{"key":"2024070511380435500_CIT0028","doi-asserted-by":"crossref","first-page":"n256","DOI":"10.1136\/bmj.n256","article-title":"Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai","volume":"372","author":"Mittra","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"2024070511380435500_CIT0029","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/ajco.12661","article-title":"Epidemiology of breast cancer in Indian women","volume":"13","author":"Malvia","year":"2017","journal-title":"Asia Pac J Clin Oncol"},{"issue":"2","key":"2024070511380435500_CIT0030","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/cncr.34526","article-title":"Effectiveness of triennial screening with clinical breast examination: 14-years follow-up outcomes of randomized clinical trial in Trivandrum, India","volume":"129","author":"Ramadas","year":"2023","journal-title":"Cancer"},{"issue":"2","key":"2024070511380435500_CIT0031","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5152\/dir.2021.20486","article-title":"Long-term population-based screening compared to National Breast Cancer Registry Data: effectiveness of screening in an emerging country","volume":"27","author":"Ozkan Gurdal","year":"2021","journal-title":"Diagn Interv Radiol"},{"issue":"9159","key":"2024070511380435500_CIT0032","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(99)02143-1","article-title":"Influence of delay on survival in patients with breast cancer: a systematic review","volume":"353","author":"Richards","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"2024070511380435500_CIT0033","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1016\/S1470-2045(21)00720-8","article-title":"Cancer in sub-Saharan Africa: a Lancet Oncology Commission","volume":"23","author":"Ngwa","year":"2022","journal-title":"Lancet Oncol"},{"issue":"2","key":"2024070511380435500_CIT0034","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ijc.33209","article-title":"Dissecting the journey to breast cancer diagnosis in sub-Saharan Africa: Findings from the multicountry ABC-DO cohort study","volume":"148","author":"Foerster","year":"2021","journal-title":"Int J Cancer"},{"issue":"11","key":"2024070511380435500_CIT0035","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1002\/cam4.3764","article-title":"Breast cancer in Zimbabwe: patterns of care and correlates of adherence in a national refferal hospital radiotherapy center cohort from 2014 to 2018","volume":"10","author":"Elmore","year":"2021","journal-title":"Cancer Med"},{"key":"2024070511380435500_CIT0036","first-page":"e0292169","article-title":"Factors leading to the late diagnosis and poor outcomes of breast cancer in Matabeleland South and the Bulawayo Metropolitan Provinces in Zimbabwe","volume-title":"PloS One.","author":"Magara","year":"2023"},{"issue":"1","key":"2024070511380435500_CIT0037","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ijc.21343","article-title":"Outcome of screening by clinical examination of the breast in a trial in the Philippines","volume":"118","author":"Pisani","year":"2006","journal-title":"Int J Cancer"},{"key":"2024070511380435500_CIT0038","doi-asserted-by":"crossref","first-page":"101936","DOI":"10.1016\/j.pmedr.2022.101936","article-title":"Breast and cervical cancer screening in the Philippines: challenges and steps forward","volume":"29","author":"Ho","year":"2022","journal-title":"Prev Med Rep"},{"key":"2024070511380435500_CIT0039","doi-asserted-by":"crossref","first-page":"171792","DOI":"10.1155\/2012\/171792","article-title":"Imaging-assisted large-format breast pathology: program rationale and development in a nonprofit health system in the United States","volume":"2012","author":"Tucker","year":"2012","journal-title":"Int J Breast Cancer."},{"issue":"25","key":"2024070511380435500_CIT0040","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1200\/JCO.2014.56.3361","article-title":"Pre-operative magnetic resonance imaging and large-format breast pathology: closing the loop","volume":"32","author":"Peralta","year":"2014","journal-title":"J Clin Oncol"},{"issue":"2","key":"2024070511380435500_CIT0041","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10549-015-3626-6","article-title":"A randomized controlled trial of cognitive-behavioral stress management in breast cancer: survival and recurrence at 11-year follow-up","volume":"154","author":"Stagl","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"2024070511380435500_CIT0042","volume-title":"NCCN Clinical Practice Guidelines in Oncology: Distress Management","author":"Riba","year":"2022"},{"issue":"1","key":"2024070511380435500_CIT0043","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/1099-1611(200101\/02)10:1<19::AID-PON501>3.0.CO;2-6","article-title":"The prevalence of psychological distress by cancer site","volume":"10","author":"Zabora","year":"2001","journal-title":"Psychooncology"},{"issue":"1","key":"2024070511380435500_CIT0044","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/pon.1873","article-title":"An examination of distress, sleep, and fatigue in metastatic breast cancer patients","volume":"21","author":"Mosher","year":"2012","journal-title":"Psychooncology"},{"issue":"Suppl 2","key":"2024070511380435500_CIT0045","doi-asserted-by":"crossref","first-page":"224s","DOI":"10.1200\/jgo.18.90800","article-title":"Prevalence of psychological distress, anxiety and depression in metastatic breast cancer patients. meeting abstract: world cancer congress","volume":"4","author":"Travado","year":"2018","journal-title":"J Glob Oncol."},{"key":"2024070511380435500_CIT0046","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.breast.2020.02.003","article-title":"The EUSOMA requirements of a specialist breast centre","volume":"51","author":"Biganzoli","year":"2020","journal-title":"Breast"},{"key":"2024070511380435500_CIT0047","author":"NICE","year":"2004"},{"key":"2024070511380435500_CIT0048","volume-title":"Patient-Centered in Communication in Cancer Care: Promoting Healing and Reducing Suffering","author":"Epstein","year":"2007"},{"key":"2024070511380435500_CIT0049","article-title":"Survivorship and rehabilitation: policy recommendations for quality improvement in cancer survivorship and rehabilitation in EU Member States","volume-title":"European Guide on Quality Improvement in Comprehensive Cancer Control","author":"Albreht","year":"2017"},{"issue":"1","key":"2024070511380435500_CIT0050","first-page":"22","article-title":"The direct medical cost of breast cancer: a case study in one hospital","volume":"14","author":"Lemhouer","year":"2020","journal-title":"Belg J Med Oncol."},{"issue":"1","key":"2024070511380435500_CIT0051","first-page":"23","article-title":"Comparison of treatment costs for breast cancer by tumor stage and type of service: a population based approach","volume":"9","author":"Blumen","year":"2016","journal-title":"Am Health Drug Benefits"},{"issue":"3","key":"2024070511380435500_CIT0052","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00520-016-3446-1","article-title":"Return to work among breast cancer survivors: a literature review","volume":"25","author":"Sun","year":"2017","journal-title":"Support Care Cancer"},{"issue":"Suppl 2","key":"2024070511380435500_CIT0053","first-page":"e000861","article-title":"Breast cancer: global quality care delivery with existing financial and personnel resources","volume":"4","author":"Verhoeven","year":"2020","journal-title":"ESMO Open"},{"issue":"10","key":"2024070511380435500_CIT0054","doi-asserted-by":"crossref","first-page":"e0223537","DOI":"10.1371\/journal.pone.0223537","article-title":"Patient navigation services for cancer care in low-and middle-income countries: a scoping review","volume":"14","author":"Dalton","year":"2019","journal-title":"PLoS One"},{"issue":"26","key":"2024070511380435500_CIT0055","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMp1011024","article-title":"What is value in health care","volume":"363","author":"Porter","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"2024070511380435500_CIT0056","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/ACM.0000000000003122","article-title":"Defining and implementing value-based health care: a strategic framework","volume":"95","author":"Teisberg","year":"2020","journal-title":"Acad Med"},{"key":"2024070511380435500_CIT0057","volume-title":"US Health Care From a Global Perspective, 2019. Higher Spending: Worse Outcomes?","author":"Tikkanen","year":"2020"},{"key":"2024070511380435500_CIT0058","first-page":"e1406","article-title":"Economic evaluations of breast cancer in low- and middle-income countries: a scoping review","volume-title":"The Oncologist","author":"Erfani","year":"2021"},{"key":"2024070511380435500_CIT0059","year":"2019"},{"key":"2024070511380435500_CIT0060","doi-asserted-by":"crossref","first-page":"100335","DOI":"10.1016\/j.jcpo.2022.100335","article-title":"Cancer control funding in nigeria: a case for universal health coverage","volume":"32","author":"Ndoh","year":"2022","journal-title":"J Cancer Policy."},{"key":"2024070511380435500_CIT0061","volume-title":"What is the Status of Women\u2019s Health and Health Care in the US Compared to Ten Other Countries. Commonwealth Fund Issue Briefs","author":"Munira","year":"2018"},{"issue":"2","key":"2024070511380435500_CIT0062","doi-asserted-by":"crossref","first-page":"e2255388","DOI":"10.1001\/jamanetworkopen.2022.55388","article-title":"Financial toxicity among patients with breast cancer worldwide. A systematic review and meta-analysis","volume":"6","author":"Ehsan","year":"2023","journal-title":"JAMA Netw Open."},{"issue":"3","key":"2024070511380435500_CIT0063","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/S1470-2045(22)00060-2","article-title":"6-Month or 12-month adjuvant trastuzumab regimen for HER2-positive breast cancer? Decision-making in a resource-limited setting","volume":"23","author":"Becerra-Chauca","year":"2022","journal-title":"Lancet Oncol"},{"issue":"10237","key":"2024070511380435500_CIT0064","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Adrian","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"2024070511380435500_CIT0065","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1093\/annonc\/mdx310","article-title":"ESMO-magnitude of clinical benefit scale version 1.1","volume":"28","author":"Cherny","year":"2017","journal-title":"Ann Oncol"},{"issue":"23","key":"2024070511380435500_CIT0066","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1200\/JCO.2015.61.6706","article-title":"American society of clinical oncology statement: a conceptual framework to assess the value of cancer treatment options","volume":"33","author":"Schnipper","year":"2015","journal-title":"J Clin Oncol"},{"issue":"5","key":"2024070511380435500_CIT0067","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1470-2045(21)00071-1","article-title":"The global breast cancer initiative: a strategic collaboration to strengthen health care for non-communicable diseases","volume":"22","author":"Anderson","year":"2021","journal-title":"Lancet Oncol"},{"key":"2024070511380435500_CIT0068","first-page":"50","volume-title":"Improving breast cancer outcomes in Asia Cancer Control","author":"Yip","year":"2017"},{"issue":"4","key":"2024070511380435500_CIT0069","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.annonc.2020.01.008","article-title":"Pan-Asian ADAPTED ESMO clinical practice guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS","volume":"31","author":"Park","year":"2020","journal-title":"Ann Oncol"},{"key":"2024070511380435500_CIT0070","volume-title":"Reflecting poorly: healthcare in the US compared to other high-income countries","author":"Schneider"},{"key":"2024070511380435500_CIT0071","author":"NIH"},{"issue":"3","key":"2024070511380435500_CIT0072","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJMp2112233","article-title":"Combating structural inequities-diversity, equity, and inclusion in clinical and translational research","volume":"386","author":"Boulware","year":"2022","journal-title":"N Engl J Med"},{"key":"2024070511380435500_CIT0073"},{"issue":"3","key":"2024070511380435500_CIT0074","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ejca.2012.09.014","article-title":"Breast cancer research in Asia: adopt or adapt Western knowledge","volume":"49","author":"Nirmala","year":"2013","journal-title":"Eur J Cancer"},{"issue":"10","key":"2024070511380435500_CIT0075","doi-asserted-by":"crossref","first-page":"e052098","DOI":"10.1136\/bmjopen-2021-052098","article-title":"Multicentric study to evaluate the effectiveness of Thermalytix as compared with standard screening modalities in subjects who show possible symptoms of suspected breast cancer","volume":"11","author":"Singh","year":"2021","journal-title":"BMJ Open."},{"issue":"5","key":"2024070511380435500_CIT0076","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMp2213809","article-title":"Behind-the-scenes investment for equity in global health research","volume":"388","author":"Haberer","year":"2023","journal-title":"N Engl J Med"},{"key":"2024070511380435500_CIT0077","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1200\/GO.20.00255","article-title":"Choosing wisely Africa: ten low-value or harmful practices that should be avoided in cancer care","volume":"6","author":"Rubagumya","year":"2020","journal-title":"JCO Glob Oncol."},{"key":"2024070511380435500_CIT0078","article-title":"What\u2019s the difference between equity and equality","year":"2020"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/advance-article-pdf\/doi\/10.1093\/oncolo\/oyae080\/58448977\/oyae080.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/advance-article-pdf\/doi\/10.1093\/oncolo\/oyae080\/58448977\/oyae080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T11:39:02Z","timestamp":1720179542000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/29\/7\/e899\/7680293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":78,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,5,23]]},"published-print":{"date-parts":[[2024,7,5]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyae080","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,5,23]]}}}